Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed with Chemoradiation and Consolidation in NSCLC
NCT00482014Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2007
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Eli Lilly and Company. Started May 2007; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00482014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482014.